aXichem H1 operating loss narrows to SEK 7.11 million; net sales fall to SEK 7.86 million
Reuters2026/08/27 06:31- aXichem posted first-half net sales of SEK 7.86 million, down 21.7% from a year earlier.
- Operating loss narrowed to SEK 7.11 million; net loss improved to SEK 7.17 million, with EPS of SEK -0.11.
- Second-quarter net sales fell 39.4% to SEK 4.03 million, while operating loss widened to SEK 4.29 million.
- Cash and cash equivalents totaled SEK 2.87 million at June 30; equity ratio rose 3 percentage points to 93%.
- EFSA published a positive opinion on EU approval for phenylcapsaicin in chicken feed; management expects a Commission decision by end-2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Why hasn’t the rise in US Treasury yields boosted the US dollar exchange rate?
Gurman predicts iPhone Duo: The first foldable may set industry standards, Apple (AAPL.US) foldable could trigger a decade-long upgrade cycle
Renowned financial journalist Mark Gurman stated that Apple’s first foldable iPhone has the potential to elevate the still-experimental foldable phone category to an industry standard. He noted that this device, called the iPhone Duo, is one of Apple’s most influential products, ranking just behind the iMac, iPod, iPad, and Apple Watch.
Element Fleet drops bid for FleetPartners, exits sale process
Anchoring to Nasdaq! Anthropic races toward a record-breaking IPO with fundraising scale targeting SpaceX
Sources indicate that Anthropic PBC has chosen Nasdaq as its listing venue, and the potential IPO is expected to set a historic record.
Crypto prices
More
